Bevacizumab
Links shared publicly online about this topic
Avastin (bevacizumab) Information
fda.gov — “Avastin (bevacizumab) Information” View full resource at fda.gov
Most Recently Shared on June 29, 2011 at 8:49 pm By:
Bob Finn - Medical News Net Health News
Stay tuned for story from Internal Medicine News RT @FDA_Drug_Info: CDER Media Statement on Avastin Hearing: http://1.usa.gov/AvastinT
ingentaconnect Bevacizumab costly for ovarian cancer
ingentaconnect.com — “ingentaconnect Bevacizumab costly for ovarian cancer” View full resource at ingentaconnect.com
Most Recently Shared on March 23, 2011 at 3:08 am By:
Bevacizumab costly for ovarian cancer: (Source: PharmacoEconomics and Outcomes News)MedWorm Sponsor Message: Wat... http://bit.ly/f7ExB1
Pediatrics Medical News about Bevacizumab
mdlinx.com — “Use of 532-nm Pulsed Potassium Titanyl Phosphate Laser and Adjuvant Intralesional Bevacizumab for Aggressive Respiratory Papillomatosis in Children” View full resource at mdlinx.com
Most Recently Shared on June 24, 2010 at 12:18 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Use of 532-nm Pulsed Potassium Titanyl Phosphate Laser and Adjuvant Intralesional Bevacizumab for Aggressive ... http://bit.ly/aQemRh #peds
Oncology Medical News about bevacizumab
mdlinx.com — “Treatment of advanced and/or metastatic colorectal cancer with bevacizumab in combination with oxaliplatin-based chemotherapy (Folfox7 regimen)” View full resource at mdlinx.com
Most Recently Shared on May 25, 2010 at 9:19 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Treatment of advanced and/or metastatic colorectal cancer with bevacizumab in combination with oxaliplati... http://bit.ly/aEBGpI #oncology
Research Interest in Bevacizumab Remains Robust
onclive.com — “Despite controversy over its breast cancer approval status, bevacizumab (Avastin) remains at center stage when it comes to antiangiogenic therapies for the disease.” View full resource at onclive.com
Most Recently Shared on October 6, 2011 at 9:10 pm By:
Research Interest in Bevacizumab (Avastin) Remains Robust http://ow.ly/6PQuQ
FDA Approval for Bevacizumab - National Cancer Institute
cancer.gov — “Information from the FDA about the approval of this drug and the clinical trials that led to the approval.” View full resource at cancer.gov
Most Recently Shared on December 17, 2010 at 2:17 am By:
NCI Cancer Bulletin Health News
FDA begins process to remove breast cancer indication from Avastin label http://bit.ly/f6iiRo NCI has info on Avastin http://bit.ly/eWsNNG
New Data on Bevacizumab (Avastin) « Medical Lessons
medicallessons.net — “New Data on Bevacizumab (Avastin) « Medical Lessons” View full resource at medicallessons.net
Most Recently Shared on March 7, 2011 at 11:38 pm By:
elaine schattner Oncologist, Hematologist, Physician, Doctor, and Internist
New Data on Bevacizumab (Avastin) - http://bit.ly/fyPIir
Fatal Adverse Events With Bevacizumab | Oral Cancer News
oralcancernews.org — “Fatal Adverse Events With Bevacizumab | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on March 2, 2011 at 6:26 pm By:
The Oral Cancer Foundation Health Organization
RT @Oralcancerfnd Fatal Adverse Events With Bevacizumab http://bit.ly/g8dLcm
Bevacizumab beats Photodynamic therapy for myopic SRN
eyedocnews.com — “Bevacizumab again demonstrates better results compared to laser” View full resource at eyedocnews.com
Most Recently Shared on September 21, 2009 at 2:38 pm By:
Dr. Ari Weitzner Physician, Doctor, and Ophthalmologist
Discuss: Bevacizumab Better Than PDT for Myopic Choroidal Neovascularization: By Dr. Ari WeitznerYet ano.. http://bit.ly/3VtL2
ingentaconnect Bevacizumab: Hypertension, and first report of amenorrhoea and mi...
ingentaconnect.com — “ingentaconnect Bevacizumab: Hypertension, and first report of amenorrhoea and mi...” View full resource at ingentaconnect.com
Most Recently Shared on January 15, 2012 at 1:28 am By:
Bevacizumab: Hypertension, and first report of amenorrhoea and migraines: 2 case reports: (Source: Reactions)Med... http://t.co/37lZ89V3
Combination of subconjunctival, intracorneal bevacizumab reduces corneal neovascularization
osnsupersite.com — “A study examining the use of combined subconjunctival and intracorneal injections of bevacizumab found a reduction in the neovascularized area for all” View full resource at osnsupersite.com
Most Recently Shared on October 7, 2011 at 7:09 pm By:
Combination of subconjunctival, intracorneal bevacizumab reduces corneal neovascularization: http://j.mp/nP6ymh
Trial to examine intravitreal bevacizumab for ROP management
osnsupersite.com — “KIAWAH ISLAND, S.C. " An ongoing clinical trial will attempt to answer whether intravitreal bevacizumab is a better alternative to laser therapy in ma” View full resource at osnsupersite.com
Most Recently Shared on May 29, 2009 at 3:21 pm By:
From Kiawah Eye 2009: Trial to examine intravitreal bevacizumab for ROP management http://ow.ly/9SUe
CMS to reverse ruling on bevacizumab reimbursement starting in 2010
osnsupersite.com — “The Centers for Medicare and Medicaid Services will reverse a ruling that would have reduced reimbursement rates for bevacizumab, according to a press” View full resource at osnsupersite.com
Most Recently Shared on October 30, 2009 at 2:05 pm By:
Top Story: CMS to reverse ruling on bevacizumab reimbursement starting in 2010 http://ow.ly/xDy6
Ipilimumab and bevacizumab drugs effective in treating metatastic melanoma
news-medical.net — “A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and are potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Dana-Farber Cancer Institute investigators.” View full resource at news-medical.net
Most Recently Shared on June 4, 2011 at 4:50 am By:
Ipilimumab and bevacizumab drugs effective in treating metatastic melanoma: A duo of drugs, each targeting a pri... http://bit.ly/lsbRO8
MicroRNA May Predict Response to Bevacizumab
onclive.com — “The results of a small clinical trial showed that low-level expression of a microRNA correlated with improved progression-free survival” View full resource at onclive.com
Most Recently Shared on April 28, 2011 at 3:01 pm By:
MicroRNA May Predict Response to Bevacizumab (Avastin) in Advanced Ovarian Cancer http://goo.gl/OcVAM
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Bob Finn - Medical News Net
Bringing you the latest news from scientific meetings and the policy world. Check us out at www.internalmedicinenews.com
-
Ovarian Cancer OW
Organizing ovarian cancer resources shared by health experts, advocates, and organizations into WisdomCards.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
